fda bpc-157 compounding safety risks issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of EVEXIAS Life Sciences filing lawsuit

Vascular or Cardiovascular Effects (Theoretical Risk) Because BPC-157 stimulates angiogenesis and influences the nitric oxide (NO) system, some experts caution about excessive vascular growth or dysregulation in susceptible individuals

The mechanism linking GLP-1 receptor agonists to pancreatitis remains unclear, and causality has not been definitively established, but vigilance for symptoms is warranted

NAD and NMN : biologically interesting, clinically unproven

What If Youre Not Deficient

This receptor-level mechanism distinguishes the fragment from other growth hormone fragments and mimetics and makes it a valuable tool compound in studies of selective adipose metabolism and thermogenic physiology